StreetInsider.com News Articles

GENOMMA LAB INTERNACIONAL ANNOUNCES SIXTEENTH DIVIDEND PAYMENT

Mon, 29 Jun 2026 16:10:00 -0400

MEXICO CITY, June 29, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that today it completed the payment of the cash dividend previously announced through a Notice of Rights filed with the Mexican Stock Exchange (Bolsa Mexicana de Valores).

The dividend amounted to $0.200000 Mexican pesos per share on its common stock, representing a total distribution of $200,000,000.00 M.N. (two hundred million pesos

GENOMMA LAB INTERNACIONAL ANNOUNCES SIXTEENTH DIVIDEND PAYMENT

Mon, 29 Jun 2026 16:10:00 -0400

The dividend amounted to $0.200000 Mexican pesos per share on its common stock, representing a total distribution of $200,000,000.00 M.N. (two hundred million pesos

GENOMMA LAB INTERNACIONAL ANNOUNCES SIXTEENTH DIVIDEND PAYMENT

Mon, 29 Jun 2026 16:10:00 -0400

The dividend amounted to $0.200000 Mexican pesos per share on its common stock, representing a total distribution of $200,000,000.00 M.N. (two hundred million pesos

GENOMMA LAB INTERNACIONAL ANNOUNCES SIXTEENTH DIVIDEND PAYMENT

Mon, 29 Jun 2026 16:10:00 -0400

The dividend amounted to $0.200000 Mexican pesos per share on its common stock, representing a total distribution of $200,000,000.00 M.N. (two hundred million pesos

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri

"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared

Genomma Lab Internacional Announces Results for the First Quarter 2026

Wed, 22 Apr 2026 20:07:00 -0400

MEXICO CITY, April 22, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS), unless otherwise noted.

Comments from Genomma's CEO, Marco Sparvieri
"Q1 2026 like-for-like sales declined -3.9% mainly reflecting a weak consumption environment in Mexico and continued disruptions in US Hispanic retail, partially offset by a +5.3% like-for-like increase compared